Echocardiographic data further documented that inhibition of the pro-hypertrophic AT1 receptor by losartan treatment counteracted the phenotype of cardiac hypertrophy in Tg-RKIP mice (Figure 12D). Here, AGTR1 is linked to cardiac hypertrophy.